Tenax Therapeutics Inc. (TENX)
Tenax Therapeutics Statistics
Share Statistics
Tenax Therapeutics has 4.15M shares outstanding. The number of shares has increased by 102.75% in one year.
Shares Outstanding | 4.15M |
Shares Change (YoY) | 102.75% |
Shares Change (QoQ) | 16.47% |
Owned by Institutions (%) | 1.31% |
Shares Floating | 3.63M |
Failed to Deliver (FTD) Shares | 1.83K |
FTD / Avg. Volume | 4.84% |
Short Selling Information
The latest short interest is 336.1K, so 8.1% of the outstanding shares have been sold short.
Short Interest | 336.1K |
Short % of Shares Out | 8.1% |
Short % of Float | 10.13% |
Short Ratio (days to cover) | 19.54 |
Valuation Ratios
The PE ratio is -53.71 and the forward PE ratio is -2.69. Tenax Therapeutics's PEG ratio is 0.54.
PE Ratio | -53.71 |
Forward PE | -2.69 |
PS Ratio | 0 |
Forward PS | 0.1 |
PB Ratio | 10.28 |
P/FCF Ratio | -63.83 |
PEG Ratio | 0.54 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Tenax Therapeutics.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.6, with a Debt / Equity ratio of 0.
Current Ratio | 20.6 |
Quick Ratio | 20.6 |
Debt / Equity | 0 |
Debt / EBITDA | - |
Debt / FCF | 0 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $-4.4M |
Employee Count | 4 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 63.22% in the last 52 weeks. The beta is 1.87, so Tenax Therapeutics's price volatility has been higher than the market average.
Beta | 1.87 |
52-Week Price Change | 63.22% |
50-Day Moving Average | 6.05 |
200-Day Moving Average | 5.06 |
Relative Strength Index (RSI) | 52.41 |
Average Volume (20 Days) | 37.86K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | 0 |
Net Income | -17.6M |
EBITDA | 0 |
EBIT | n/a |
Earnings Per Share (EPS) | -0.12 |
Balance Sheet
The company has 94.85M in cash and 0 in debt, giving a net cash position of 94.85M.
Cash & Cash Equivalents | 94.85M |
Total Debt | 0 |
Net Cash | 94.85M |
Retained Earnings | -314.86M |
Total Assets | 96.69M |
Working Capital | 91.99M |
Cash Flow
In the last 12 months, operating cash flow was -14.81M and capital expenditures 0, giving a free cash flow of -14.81M.
Operating Cash Flow | -14.81M |
Capital Expenditures | 0 |
Free Cash Flow | -14.81M |
FCF Per Share | -0.1 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TENX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for TENX is $16, which is 167.1% higher than the current price. The consensus rating is "Buy".
Price Target | $16 |
Price Target Difference | 167.1% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Stock Splits
The last stock split was on Jan 3, 2024. It was a backward split with a ratio of 1:80.
Last Split Date | Jan 3, 2024 |
Split Type | backward |
Split Ratio | 1:80 |
Scores
Altman Z-Score | -1.12 |
Piotroski F-Score | 3 |